Lymphocyte Targeting by Peptide-Drug Conjugates

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AI052556-01A1
Agency Tracking Number: AI052556
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
ADMUNEX THERAPEUTICS, INC., 3514 CLINTON PKY, STE A-111, LAWRENCE, KS, 66047
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 LEO Gu
 (408) 245-0003
 IGU@ADMUNEX.COM
Business Contact
 THOMAS MALEFYT
Phone: (831) 659-4336
Email: tmalefyt@admunex.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The long-term objective of this work is to design bi-functional peptide-drug conjugates that specifically target leukocytes. The peptide sequences are derived from ICAM-1 and bind to LFA-1 on activated leukocytes. The

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government